TAZVERIK
Live / Registered — Registered (as of 16 Jun 2020)
What this means for you
Registered since 16 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87554273
- Registration number
- 6080490
- Mark type
- Stylized text
- Filed
- 03 Aug 2017
- Published for opposition
- 12 Dec 2017
- Registered
- 16 Jun 2020
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical products for the treatment of cancer; pharmaceutical products, namely, EZH2 inhibitory drugs
Owner
- Epizyme, Inc., Cambridge, MA, US
- Epizyme, Inc., Cambridge, MA, US
- Epizyme, Inc., Cambridge, MA, US
Prosecution history
- 16 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Oct 2022 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 16 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 14 May 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 May 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Apr 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Apr 2020 — USE AMENDMENT FILED
- 29 Apr 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Apr 2020 — TEAS STATEMENT OF USE RECEIVED
- 29 Jan 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jan 2020 — SOU EXTENSION 4 GRANTED
- 27 Jan 2020 — SOU EXTENSION 4 FILED
- 27 Jan 2020 — SOU TEAS EXTENSION RECEIVED
- 14 Jun 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jun 2019 — SOU EXTENSION 3 GRANTED